Dierdre Lane

Dr Lane is a Senior Lecturer in Cardiovascular Health at the University of Birmingham in the UK and Adjunct Professor of Cardiovascular Health at Aalborg University, Denmark. Atrial fibrillation is her main research interest focused on bleeding and stroke risk stratification and patient-centred research. She is a co-author of both the CHA2DS2-VASc stroke risk stratification score and the HAS-BLED bleeding risk score. Her other main research interest is how AF affects quality of life and psychological well-being, patient education, and patients’ perceptions of AF and medication adherence. She was the Chair for a recent European Heart Rhythm Association (EHRA) position document on ‘Cardiac tachyarrhythmias and patient values and preferences for their management’ and is a member of American College of Chest Physicians guidelines on antithrombotic therapy in AF patients. She has published her work widely in journals such as Stroke,

Chest, JACC, Thrombosis and Haemostasis, and BMJ.